We are live on ! Find out more
TCBP

TC BioPharm (Holdings) plc American Depositary Shares
TCBP

Delisted

TCBP was delisted on the 21st of March, 2025.

Back to rankings

6 hedge funds and large institutions have $380K invested in TC BioPharm (Holdings) plc American Depositary Shares in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

100% more funds holding

Funds holding: 3 → 6 (+3)

83% more capital invested

Capital invested by funds: $207K → $380K (+$173K)

Holders
6
Holders Change
+3
Holders Change %
+100%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$408K
2
Citadel Advisors
Citadel Advisors
Florida
+$77.1K
3
Renaissance Technologies
Renaissance Technologies
New York
+$70.6K
4
VF
Virtu Financial
New York
+$12.8K
5
Wells Fargo
Wells Fargo
California
+$6.42K

Top Sellers

Rank Fund Capital Flow
1
SFG
Steward Financial Group
Texas
-$3K
2
Morgan Stanley
Morgan Stanley
New York
-$32

TCBP Hedge Fund Activity: Q2 2023 in Review

6 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc American Depositary Shares (TCBP) for Q2 2023, worth a combined $380K — up 83% from $207K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new TCBP positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Armistice Capital, adding an estimated $408K. The largest seller was Steward Financial Group, exiting entirely with an estimated $3K sold.

  • 6 institutional investors held TC BioPharm (Holdings) plc American Depositary Shares (TCBP) as of Q2 2023, up from 3 in Q1 2023.
  • Funds reported $380K of TC BioPharm (Holdings) plc American Depositary Shares stock for Q2 2023, up 83% quarter-over-quarter.
  • 4 funds opened new TC BioPharm (Holdings) plc American Depositary Shares positions in Q2 2023 and 1 closed out, a net change of +3 holders.
  • The largest TC BioPharm (Holdings) plc American Depositary Shares buyer in Q2 2023 was Armistice Capital, an estimated $408K added.
  • The largest TC BioPharm (Holdings) plc American Depositary Shares seller in Q2 2023 was Steward Financial Group, an estimated $3K sold.

Based on aggregated 13F filings for Q2 2023.